Roxbury Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$114K Buy
1,325
+5
+0.4% +$441 0.09% 140
2026
Q2
$103K Sell
1,320
-1,632
-55% -$132K 0.08% 142
2026
Q1
$256K Buy
2,952
+16
+0.5% +$1.53K 0.23% 79
2025
Q4
$282K Sell
2,936
-9
-0.3% -$874 0.25% 70
2025
Q3
$280K Sell
2,945
-23
-0.8% -$2.11K 0.26% 70
2025
Q2
$259K Sell
2,968
-72
-2% -$6.11K 0.25% 73
2025
Q1
$280K Buy
3,040
+17
+0.6% +$1.52K 0.27% 71
2024
Q4
$262K Buy
+3,023
New +$262K 0.25% 73

Other funds holding MDT

Roxbury Financial's MDT Position: Q3 2026 in Review

Roxbury Financial increased its Medtronic (MDT) stake by 0.38% in Q3 2026, buying an estimated $441 and bringing the position to 1,325 shares worth $114K. The position accounts for 0.09% of the portfolio, ranked #140.

Roxbury Financial first reported a position in MDT in Q4 2024 and has held it in 8 quarters since. The position peaked at $282K in Q4 2025. 1,398 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Roxbury Financial held 1,325 shares of Medtronic worth $114K as of Q3 2026.
  • Roxbury Financial bought 5 Medtronic shares in Q3 2026, an estimated $441.
  • Medtronic made up 0.09% of Roxbury Financial's portfolio in Q3 2026, its #140 holding.
  • Roxbury Financial first reported a position in Medtronic in Q4 2024 and has held it in 8 quarters since.
  • Roxbury Financial's Medtronic position peaked at $282K in Q4 2025.
  • 1,398 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.